`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`________________
`
`APOTEX INC., APOTEX CORP., APOTEX PHARMACEUTICALS
`HOLDINGS INC., and APOTEX HOLDINGS, INC.,
`Petitioners,
`
`v.
`
`OSI PHARMACEUTICALS, INC.,
`Patent Owner.
`________________
`
`U.S. Patent No. 6,900,221
`Issue Date: May 31, 2005
`Title of Patent: Stable Polymorph on N-(3-ethylphenyl)-6,7-bis(2methoxyethoxy)-
`4-quinazolinamine hydrochloride, Methods of Production,
`and Pharmaceutical uses thereof
`________________
`
`Case No.: IPR2016-01284
`________________
`
`DECLARATION OF KERRY B. MCTIGUE IN SUPPORT OF MOTION
`FOR ADMISSION PRO HAC VICE
`
`
`
`
`
`
`
`
`
`
`
`
`
`LEGAL\31501542\1
`
`APOTEX EX. 1029-001
`
`
`
`
`
`I, Kerry B. McTigue, declare as follows:
`
`IPR2016-01284
`U.S. Patent No. 6,900,221
`Declaration of Kerry B. McTigue
`
`1. I was admitted to the State of Kentucky Bar in 1996 and the State of
`
`South Carolina Bar in 2001. I have been practicing law for 21 years. For more than
`
`10 years, my practice has focused primarily on patent litigation in the life sciences.
`
`2. Over the course of my career, I have been lead counsel in numerous of
`
`patent litigations. I am currently Co-Chair of Cozen O’Connor’s Intellectual
`
`Property Department with supervisory authority over Cozen O’Connor patent
`
`litigations.
`
`3. My Kentucky Bar membership number is, 86541, though currently on
`
`inactive status. My South Carolina Bar membership number is 68553.
`
`4. I am admitted, practicing and in good standing as a member of the Bar of
`
`the State of South Carolina as well as the Bar of the State of Kentucky, though
`
`currently on inactive status in the latter. I am admitted to practice before the U.S.
`
`District Courts for South Carolina and the Western District of Missouri. I am also
`
`admitted to practice before the U.S. Supreme Court, U.S. Court of Appeals for the
`
`Federal Circuit, the U.S. Court of Appeals for the Fourth Circuit, and U.S. Court of
`
`Federal Claims.
`
`5. I have never been suspended or disbarred from practice before any court
`
`or administrative body.
`
`2
`
`APOTEX EX. 1029-002
`
`
`
`6. I have never had a court or administrative body deny my application for
`
`IPR2016-01284
`U.S. Patent No. 6,900,221
`Declaration of Kerry B. McTigue
`
`
`
`admission to practice.
`
`7. I have never had any sanctions or contempt citations imposed by any
`
`court or administrative body.
`
`8. I have read and will comply with the Patent Office Trial Practice Guide
`
`and the Board’s Rules for Practice for Trials, as set forth in 37 C.F.R. Part 42.
`
`9. I agree to be subject to the United States Patent and Trademark Office
`
`Rules of Professional Conduct set forth in 37 C.F.R. §§ 11.101 et seq. and
`
`disciplinary jurisdiction under 37 C.F.R. § 11.19(a).
`
`10. I have not appeared Pro Hac Vice before the Patent Trial and Appeal
`
`Board.
`
`11. In addition to this matter, I have represented Apotex Inc. and Apotex
`
`Corp. and/or their parent or subsidiary companies, in numerous patent and patent-
`
`related matters, including: OSI Pharmaceuticals, LLC v. Apotex Inc., No. 1:15-cv-
`
`00772 (D. Del.); Amgen Inc., et al. v. Apotex Inc., et al. 0:15-cv-61631-
`
`COHN/SELTZER (S.D. Fla.); and Amgen Inc., et al. v. Apotex Inc., et al. 17-1010
`
`(Fed. Cir.).
`
`12. I am familiar with the subject matter of U.S. Patent No. 6,900,221. I am
`
`also familiar with tyrosine kinase inhibitor technology as a result of my
`
`participation as counsel in cases related to such subject matter, including the cases
`
`3
`
`APOTEX EX. 1029-003
`
`
`
`
`listed in the previous paragraph. In addition, I have represented a number of life
`
`IPR2016-01284
`U.S. Patent No. 6,900,221
`Declaration of Kerry B. McTigue
`
`sciences and pharmaceutical companies including Apotex Inc. and Endo
`
`Pharmaceuticals Inc. in many patent litigation matters before federal district courts
`
`and appellate courts. In particular, I have extensive experience with secondary
`
`considerations of non-obviousness and financial aspects thereof in patent litigation.
`
`
`
`13. I hereby declare that all statements made herein of my own knowledge
`
`are true and that all statements made on information and belief are believed to be
`
`true; and further that these statements are made with the knowledge that willful
`
`false statements and the like are punishable by fine, imprisonment, or both under
`
`Section 1001 of Title 18 of the United States Code.
`
`
`
`
`
`
`
`
`
`Dated: July 6, 2017
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully Submitted,
`
`/Kerry B. McTigue/
`Kerry B. McTigue
`
`
`
`
`
`
`
` COZEN O’CONNOR PC
` 1200 Nineteenth St. N.W.
`
`Washington, D.C. 20036
` 202-912-4810
` kmctigue@cozen.com
`
`
`
`4
`
`APOTEX EX. 1029-004
`
`